Using proteomics to identify potential therapeutic targets in platelets

被引：15
作者：
Maguire, FB [1 ]
Foy, M [1 ]
Fitzgerald, DJ [1 ]
机构：
[1] Univ Coll Dublin, Conway Inst, Dept Mol Med, Dublin 4, Ireland
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 2005年 / 33卷
关键词：
MS; membrane lipid raft; platelet phosphoproteome; platelet releasate; platelet; proteomics;
D O I：
10.1042/BST0330409
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Proteomics has provided powerful new insights into the complex events of the anucleate platelet and has revealed many potential protein targets in the search for suitable agents for thrombotic disease. in the present study, we summarize recent proteomic approaches to analyse specific platelet subproteomes, such as the platelet releasate, the platelet phosphotyrosine proteome and characterization of the proteins associated with membrane lipid rafts.
引用
收藏
页码：409 / 412
页数：4
相关论文
共 50 条
  • [41] Metabolic crosstalk between platelets and cancer: Mechanisms, functions, and therapeutic potential
    Chen, Zhixue
    Xu, Lin
    Yuan, Yejv
    Zhang, Si
    Xue, Ruyi
    SEMINARS IN CANCER BIOLOGY, 2025, 110 : 65 - 82
  • [42] CD-XX is a novel potential therapeutic target in uterine leiomyosarcoma as identified using plasma membrane proteomics
    Nakae, Ruriko
    Matsuzaki, Shinya
    Nakagawa, Satoshi
    Okazawa, Akiko
    Iwamiya, Tadashi
    Kobayashi, Eiji
    Ueda, Yutaka
    Yoshino, Kiyoshi
    Serada, Satoshi
    Naka, Tetsuji
    Kimura, Tadashi
    CANCER SCIENCE, 2018, 109 : 131 - 131
  • [43] Amniotic Fluid Proteomics Analysis and In Vitro Validation to Identify Potential Biomarkers of Preterm Birth
    Chen, Siguo
    Wang, Weizhou
    Yan, Guanghong
    Liu, Mengmei
    Li, Min
    Chen, Ping
    Ma, Qingyan
    Zhang, Jinman
    Tang, Ying
    Zhou, Linglin
    You, Dingyun
    REPRODUCTIVE SCIENCES, 2024, 31 (07) : 2032 - 2042
  • [44] Proteomics-based discovery of biomarkers and therapeutic targets in neurodegenerative diseases: perspective of microglia and neuroinflammation
    Suk, K
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (03) : 237 - 247
  • [45] Using genomics to identify new targets and counteract resistance to antibiotics
    Alvarez, Javier
    Vicente, Miguel
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (06) : 667 - 674
  • [46] Integrative analysis of network pharmacology and proteomics to identify key targets of Tuomin-Zhiti-Decoction for allergic rhinitis
    Cheng, Jinjun
    Zhang, Meiling
    Zheng, Yanfei
    Wang, Ji
    Wang, Qi
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 296
  • [47] Metabolomics and proteomics identify the toxic form and the associated cellular binding targets of the anti-proliferative drug AICAR
    Douillet, Delphine C.
    Pinson, Benoit
    Ceschin, Johanna
    Huerlimann, Hans C.
    Saint-Marc, Christelle
    Laporte, Damien
    Claverol, Stephane
    Konrad, Manfred
    Bonneu, Marc
    Daignan-Fornier, Bertrand
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (03) : 805 - 815
  • [48] Study on therapeutic effects of Huperzine A on Alzheimer disease using proteomics
    Geng, miao
    Zhou, wen-xia
    Zhang, yong-xiang
    Yang, xin-bo
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 368 - 368
  • [49] Using Neural Networks to Identify More Proteins in High-Throughput Proteomics
    McHugh, Leo
    Arthur, Jonathan
    2009 WORLD CONGRESS ON NATURE & BIOLOGICALLY INSPIRED COMPUTING (NABIC 2009), 2009, : 1676 - 1679
  • [50] Quantitative proteomics of vitreous humor to identify potential markers involved in the induction of posterior vitreous detachment
    Keshavamurthy, Ravi
    Koh, Jin
    Chen, Sixue
    Chalam, K. V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
12345